Acticor Biotech (XPAR:ALACT) YoY EBITDA Growth : -4.82% (As of Jun. 2023)

View and export this data going back to 2021. Start your Free Trial

What is Acticor Biotech YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. Acticor Biotech's YoY EBITDA Growth for the quarter that ended in Jun. 2023 was -4.82%.

Acticor Biotech's EBITDA per Share for the six months ended in Jun. 2023 was €-0.72.

Acticor Biotech YoY EBITDA Growth Historical Data

The historical data trend for Acticor Biotech's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Acticor Biotech YoY EBITDA Growth Chart

Acticor Biotech Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

YoY EBITDA Growth

Get a 7-Day Free Trial

17.84

-61.76

-111.89

5.94

Acticor Biotech Semi-Annual Data
	Dec18	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23
YoY EBITDA Growth	Get a 7-Day Free Trial				-70.57	-43.72	-26.90	-27.62	-4.82

Acticor Biotech YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

Acticor Biotech's YoY EBITDA Growth for the fiscal year that ended in Dec. 2022 is calculated as:

	YoY EBITDA Growth (A: Dec. 2022 )
=	(EBITDA per Share (A: Dec. 2022 )	-	EBITDA per Share (A: Dec. 2021 ))	/	\| EBITDA per Share (A: Dec. 2021 ) \|
=	(-1.425	-	-1.515)	/	\| -1.515 \|
=	5.94 %

Acticor Biotech's YoY EBITDA Growth for the quarter that ended in Jun. 2023 is calculated as:

	YoY EBITDA Growth (Q: Jun. 2023 )
=	(EBITDA per Share (Q: Jun. 2023 )	-	EBITDA per Share (Q: Jun. 2022 ))	/	\| EBITDA per Share (Q: Jun. 2022 )) \|
=	(-0.717	-	-0.684)	/	\| -0.684 \|
=	-4.82 %

Acticor Biotech YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of Acticor Biotech's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

Acticor Biotech (XPAR:ALACT) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Acticor Biotech SA (XPAR:ALACT) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

7V7:Germany

Address

82 Avenue du Maine, Wojo Building, Paris, FRA, 75014

Website

https://www.acticor-biotech.com

Acticor Biotech SA is a clinical stage biopharmaceutical company. It is developing a treatment for cardiovascular emergencies, with a primary focus on Acute Ischemic Stroke.

Acticor Biotech (XPAR:ALACT) Headlines

No Headlines